Found: 29
Select item for more details and to access through your institution.
Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 8129, doi. 10.1007/s00520-022-07249-2
- By:
- Publication type:
- Article
Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management program.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 6, p. 5289, doi. 10.1007/s00520-022-06949-z
- By:
- Publication type:
- Article
Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 829, doi. 10.21873/invivo.11845
- By:
- Publication type:
- Article
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 404, doi. 10.4143/crt.2023.784
- By:
- Publication type:
- Article
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability-High Colon Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1175, doi. 10.4143/crt.2021.1133
- By:
- Publication type:
- Article
Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 2, p. 505, doi. 10.4143/crt.2020.1198
- By:
- Publication type:
- Article
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 226, doi. 10.4143/crt.2021.365
- By:
- Publication type:
- Article
Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 4, p. 1166, doi. 10.4143/crt.2021.091
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 424, doi. 10.4143/crt.2020.953
- By:
- Publication type:
- Article
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxPS<sup>-</sup> CD4<sup>+</sup> T Cells in Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 1, p. 162, doi. 10.4143/crt.2020.704
- By:
- Publication type:
- Article
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair--Deficient/Microsatellite Instability--High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1135, doi. 10.4143/crt.2020.218
- By:
- Publication type:
- Article
Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12268-9
- By:
- Publication type:
- Article
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11972-w
- By:
- Publication type:
- Article
Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4723, doi. 10.3390/cancers14194723
- By:
- Publication type:
- Article
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 107, doi. 10.1159/000512781
- By:
- Publication type:
- Article
Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5558, doi. 10.1002/cam4.5400
- By:
- Publication type:
- Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 705, doi. 10.1002/cam4.4476
- By:
- Publication type:
- Article
Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 10, p. 3197, doi. 10.1002/cam4.3874
- By:
- Publication type:
- Article
Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1034, doi. 10.1002/cam4.1994
- By:
- Publication type:
- Article
Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1390452
- By:
- Publication type:
- Article
Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82534-4
- By:
- Publication type:
- Article
Authors' Reply to Yusuf Ziya Sener: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictive biomarkers for the efficacy of nivolumab as ≥ 3<sup>rd</sup>-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1443, doi. 10.1634/theoncologist.2019-0009
- By:
- Publication type:
- Article
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.969569
- By:
- Publication type:
- Article
3′-Deoxy-3'-<sup>18</sup>F-Fluorothymidine and <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 8, p. 1713, doi. 10.1007/s00259-019-04330-7
- By:
- Publication type:
- Article
A Critical Case of Wernicke's Encephalopathy Induced by Hyperemesis Gravidarum.
- Published in:
- 2015
- By:
- Publication type:
- Case Study